Atlas market file · Equity · Asia-Pacific
Anthem Biosciences LimitedANTHEM
- Last close
- 783.50
- Change
- -0.77%
- 96-bar range
- 625.00 – 825.60
- As of
- 30 Jul 2026
Anthem Biosciences Limited is a healthcare or life-sciences issuer listed as ANTHEM on BSE. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
- Identity
- BSE symbol identity
- Chart rail
- TradingView
- File state
- Public profile
ANTHEM
Equity · evidence first
Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.
â–® up candle â–® down candle
Weekly outlook: the last 55 weekly closes (+6.92% over the window).
Source rail: Yahoo Finance chart API (ANTHEM.BO). This dated snapshot is the crawlable Atlas reference.
Live market viewTradingView · provider feed Open view ->
Open the attributed TradingView market view for ANTHEM. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.
ANTHEM public profile
Healthcare or life-sciences issuer. Anthem Biosciences Limited is connected to current market context, cited company sources and its retained research file.
Anthem Biosciences Limited trades as ANTHEM on BSE. Anthem Biosciences Limited (ANTHEM) has a latest verified close of 783.50, down 0.77%, dated 30 Jul 2026.
Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. Atlas files ANTHEM under Science & Biotech Stocks for browsing.
Market Wit preview
Anthem Biosciences Limited arrives with an operating story before ANTHEM gets to become a market mood. Anthem Biosciences Limited is listed on BSE in Asia-Pacific with TradingView symbol BSE:ANTHEM and public listing evidence. The share can move quickly, but the business underneath usually moves through customers, products, pricing, costs, regulation, ownership, and cash with far less theatre and far more consequence. The honest opening stays with the operating record: what Anthem Biosciences Limited actually sells, what the filings and cash line show, and which disclosed number would move ANTHEM from a described claim to a proven one (source: public profile, https://atlas.freedomcore.io/stocks/ANTHEM/).
Run the full workstation report for the complete source rail, saved history, export controls, and the full Market Wit file for ANTHEM.
What changed for Anthem Biosciences Limited today
Anthem Biosciences Limited (ANTHEM) is tracked as a listed company on BSE. The public profile anchors the symbol identity, region, chart route, and research-only context for the Asia-Pacific market before any daily source layer is added.
ANTHEM is handled first as a equity file: identity, listing route, source trail, chart context, and the current limits of the public evidence set.
The deeper daily research layer expands only when fresh evidence changes the file. Until then, this page keeps the public profile, chart route, risks, catalysts, and research-only framing explicit instead of manufacturing movement for its own sake.
Sources & evidence · 1 links
This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.
ANTHEM technical readout
Directional bias up. Wilder ADX and ATR computed from Atlas approved daily OHLC through 2026-07-27. Indicators are descriptive statistics, not investment advice.
Open an Atlas research path on ANTHEM
FreedomCore Atlas can expand this public profile into source-led research files with company snapshots, valuation context, filings and segment detail, source packs, and equity briefs. Each path keeps the underlying public sources visible.
Open Atlas workstation ->Keep ANTHEM research in your Atlas archive
Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. £12/month founding price, locked for life. Research only; not investment advice.
Checking Atlas access...
ANTHEM FAQ
What is Anthem Biosciences Limited (ANTHEM)?Anthem Biosciences Limited (ANTHEM) has a latest verified close of 783.50, down 0.77%, dated 30 Jul 2026. Use this page to check the price chart, company context,...
Anthem Biosciences Limited (ANTHEM) has a latest verified close of 783.50, down 0.77%, dated 30 Jul 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
What does Atlas show for ANTHEM?Anthem Biosciences Limited (ANTHEM) has a latest verified close of 783.50, down 0.77%, dated 30 Jul 2026. It brings the latest available chart, company context, cited...
Anthem Biosciences Limited (ANTHEM) has a latest verified close of 783.50, down 0.77%, dated 30 Jul 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. Atlas files ANTHEM under Science & Biotech Stocks for browsing.
How often is the ANTHEM page updated?The ANTHEM public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows...
The ANTHEM public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.
Which sources does Atlas use for ANTHEM?The ANTHEM file starts with BSE symbol identity and TradingView BSE:ANTHEM. The page separates verified market context from company evidence and shows open evidence...
The ANTHEM file starts with BSE symbol identity and TradingView BSE:ANTHEM. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.
Can Atlas run a full research brief on ANTHEM?Yes. The workstation can open ANTHEM, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Yes. The workstation can open ANTHEM, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Is this ANTHEM page investment advice?No. The ANTHEM page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a...
No. The ANTHEM page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.
Methodology
This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.
Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.
Profile last updated: 2026-07-30. Browse FreedomCore Atlas research notes →